AW 464 - University of Nottingham

Drug Profile

AW 464 - University of Nottingham

Alternative Names: AW 464; NSC 706704

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University of Nottingham
  • Class
  • Mechanism of Action Angiogenesis inhibitors; Thioredoxin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Colorectal cancer

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Colorectal-cancer in United Kingdom
  • 30 Nov 2004 Data presented at the British Cancer Research Meeting 2004 (BCRM-2004) have been added to the Cancer pharmacodynamics section
  • 29 Nov 2004 Preclinical trials in Colorectal cancer in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top